Eric Schadt - President & Chief R&D Officer, Director at GeneDx Holdings Corp.

Insider Transactions and Holdings

Identity 2 facts
Entity type
Individual
Role
President & Chief R&D Officer, Director
Issuer context 1 fact
Issuer symbol
WGS, WGSWW on Nasdaq
SEC evidence 1 fact
Source evidence
Open source filing history

There are no Buy or Sell transactions made by Eric Schadt since 01 Jun 2025

Holdings reported by Eric Schadt for GeneDx Holdings Corp.

Form 4 holding President & Chief R&D Officer, Director

Sema4 Holdings Corp.

Security class
Class A Common Stock
Shares / value
243,380
Estimated value
$788,551
Report date
20 May 2022
Price
$3.24
Ownership
Direct

Transactions reported by Eric Schadt for GeneDx Holdings Corp.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .